These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 523855)

  • 61. Supplementary dose after hemodialysis.
    Keller F; Offermann G; Lode H
    Nephron; 1982; 30(3):220-7. PubMed ID: 7099332
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Drug therapy in the elderly (author's transl)].
    Katsunuma H
    Nihon Ronen Igakkai Zasshi; 1982 Mar; 19(2):110-20. PubMed ID: 7109302
    [No Abstract]   [Full Text] [Related]  

  • 63. Drug dosing in the elderly patients with chronic kidney disease.
    Olyaei AJ; Bennett WM
    Clin Geriatr Med; 2009 Aug; 25(3):459-527. PubMed ID: 19765493
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [How to use drugs in chronic renal insufficiency (antibiotics excepted)].
    Kleinknecht D
    Sem Hop Ther; 1976 Apr; 52(4):254-9. PubMed ID: 948770
    [No Abstract]   [Full Text] [Related]  

  • 65. Combined seminar on the use of drugs in renal failure: narcotics, psychotherapeutic agents, antiarrhythmics, antihypertensives, sorbents, vitamin D and its analogues, anabolic hormones and nutritional supplements.
    Am J Med; 1977 Apr; 62(4):527. PubMed ID: 851124
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug prescribing in renal failure.
    Bennett WM
    Drugs; 1979 Feb; 17(2):111-23. PubMed ID: 378644
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Specific antibodies and Fab fragments to alter the pharmacokinetics and reverse the pharmacologic/toxicologic effects of drugs.
    Colburn WA
    Drug Metab Rev; 1980; 11(2):223-62. PubMed ID: 7011759
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical relevance of impaired nonrenal drug clearance in ESRD.
    Nolin TD; Unruh ML
    Semin Dial; 2010; 23(5):482-5. PubMed ID: 21069923
    [No Abstract]   [Full Text] [Related]  

  • 69. Nomogram for drug dosage adjustment in patients with renal failure.
    Bjornsson TD
    Clin Pharmacokinet; 1986; 11(2):164-70. PubMed ID: 3956049
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Investigations on oxygen transport in chronic renal insufficiency (author's transl)].
    Siemon G; Wölk G; Thoma R
    Pneumonologie; 1975 Sep; 152(1-3):235-41. PubMed ID: 1187394
    [No Abstract]   [Full Text] [Related]  

  • 71. Guide to drug dosage in renal failure.
    Bennett WM
    Clin Pharmacokinet; 1988 Nov; 15(5):326-54. PubMed ID: 3060292
    [No Abstract]   [Full Text] [Related]  

  • 72. [Clinical pharmacokinetics in the causal treatment of acute intoxications (author's transl)].
    Lesne M; Jacqmin P; Bouchat JM; Mahieu P
    Therapie; 1981; 36(5):511-23. PubMed ID: 7034287
    [No Abstract]   [Full Text] [Related]  

  • 73. [Single injection clearance of alpha-ketoglutarate in chronic renal failure (author's transl)].
    Manz F; Schärer K; Alatas H; Lommel R
    Klin Wochenschr; 1974 Feb; 52(3):143-4. PubMed ID: 4826654
    [No Abstract]   [Full Text] [Related]  

  • 74. [Pharmacocinetics and dosage of dextran 40 in relation to renal function (author's transl)].
    Köhler H; Kirch W; Höffler D; Koeppe P
    Klin Wochenschr; 1974 Dec; 52(23):1111-6. PubMed ID: 4444228
    [No Abstract]   [Full Text] [Related]  

  • 75. [Hepatic galactose elimination lapacity in chronic renal insufficiency (author's transl)].
    Wernze H; Wagner F
    Klin Wochenschr; 1973 Sep; 51(18):933-5. PubMed ID: 4762194
    [No Abstract]   [Full Text] [Related]  

  • 76. Drug therapy in renal failure.
    Reidenberg MM; Drayer DE
    Annu Rev Pharmacol Toxicol; 1980; 20():45-54. PubMed ID: 6992702
    [No Abstract]   [Full Text] [Related]  

  • 77. Ranitidine reduces aluminium toxicity in patients with renal failure.
    Czapla K; Rodger RS; Halls DJ; Muralikrishna GS; Macdougall AI; Fell GS
    Nephrol Dial Transplant; 1992; 7(12):1246-8. PubMed ID: 1337167
    [No Abstract]   [Full Text] [Related]  

  • 78. The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function.
    Reidenberg MM
    Am J Med; 1977 Apr; 62(4):466-70. PubMed ID: 851114
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Model analyses of interfacial transfer and absorption behaviors of drugs following dissolution: approach to evaluation procedure of bioavailability (author's transl)].
    Uekama K; Fujisaki J; Hirayama F
    Yakugaku Zasshi; 1980 Nov; 100(11):1087-96. PubMed ID: 7205553
    [No Abstract]   [Full Text] [Related]  

  • 80. The effect of water on the absorption of drugs from the gastro-intestinal tract.
    Williams G; Maddocks JL
    Br J Clin Pharmacol; 1975 Dec; 2(6):543-6. PubMed ID: 1234020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.